MedTrace Logo

Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma

NCT03796819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2021-12-09

No results posted yet for this study

Summary

The role of routine lymphadenectomy (LND) in the surgical treatment of intrahepatic cholangiocarcinoma (ICC) remains controversial. The investigators' multi-institutional retrospective study have showed an increasing adoption of LND among patients undergoing curative resection for ICC during the last decade. The current prospective and randomized study based on a multi-institutional collaboration would investigate whether routine LND would benefit patients in short- and long-term survival remains.

Conditions

  • Intrahepatic Cholangiocarcinoma

Interventions

PROCEDURE

lymphadenectomy

Patients would undergo routine hepatoduodenal lymphadenectomy at the time of ICC resection

Sponsors & Collaborators

  • Ningxia Medical University

    collaborator OTHER

  • Nanchang University

    collaborator OTHER

  • Binzhou Medical University

    collaborator OTHER

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • Shaanxi University of Chinese Medicine

    collaborator OTHER

  • The Third Affiliated Hospital of Beijing University

    collaborator UNKNOWN

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Yi Lv, MD, PhD · First Affiliated Hospital Xi'an Jiaotong University

  • Xu-Feng Zhang, MD,PhD · First Affiliated Hospital Xi'an Jiaotong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2021-08-01
Completion
2021-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796819 on ClinicalTrials.gov